2025, Vol 3

Review Article

1. Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer

Sepideh Izadi , Mohammad Hojjat-Farsangi, Vahid Karpisheh, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2023;1: e2 | Published on: 2023 Mar 15. doi: 10.34172/ijdrc.2023.e2

Article

PDF

XML

Cited By:

Review Article

2. Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Mobina Oladghaffari* , Sama Rahnemayan , Zahra Tohid , Majid Montazer , Farnaz Dabiri

Int J Drug Res Clin. 2023;1: e19 | Published on: 2023 Nov 29. doi: 10.34172/ijdrc.2023.e19

Article

PDF

XML

Cited By:

Original Article

3. Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells

Parastoo Khodayari , Atefeh Khodakarami, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Vida Hashemi, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2023;1: e8 | Published on: 2023 May 17. doi: 10.34172/ijdrc.2023.e8

Article

PDF

XML

Cited By:

Original Article

4. IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth

Shiva Abolhasani , Sepideh Javadi, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2023;1: e17 | Published on: 2023 Nov 07. doi: 10.34172/ijdrc.2023.e17

Article

PDF

XML

Cited By:

Original Article

5. Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth

Atefeh Khodakarami , Samira Darvishi, Hadi Hassannia, Mohammad Sadeghi, Sana Esmaeeli, Vida Hashemi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2023;1: e10 | Published on: 2023 Jun 22. doi: 10.34172/ijdrc.2023.e10

Article

PDF

XML

Cited By:

Review Article

6. The Nephrotoxicity of Checkpoint Inhibitors: A Mini Review

Fariba Mahmoodpoor , Mohammadreza Ardalan, Aygun Nasibova, Mahbuba Valiyeva, Elham Ahmadian*

Int J Drug Res Clin. 2024;2: e1 | Published on: 2024 Feb 21. doi: 10.34172/ijdrc.2024.e1

Article

PDF

XML

Cited By:

Original Article

7. The Relationship Between Breast Cancer Risk Factors and Mammographic Density

Mahnaz Ranjkesh , Somayeh Shaker, Saba Mehrtabar, Mahya Ahmadpour Youshanlui, Samin Alihosseini*

Int J Drug Res Clin. 2024;2: e3 | Published on: 2024 Apr 03. doi: 10.34172/ijdrc.2024.e3

Article

PDF

XML

Cited By:

Original Article

8. Different Concentrations of Produced Recombinant TNF-α Protein Caused Different Cellular Viability in Breast Cancer Cell Lines

Sara Tirabadi , Mohammad Reza Nahai, Nazila Alizadeh, Mahya Ahmadpour Youshanlui, Behzad Baradaran*

Int J Drug Res Clin. 2024;2: e18 | Published on: 2024 Nov 13. doi: 10.34172/ijdrc.2024.e18

Article

PDF

XML

Cited By:

Original Article

9. Combined Blockade of Interleukin-6 and β-Catenin Inhibits Breast and Colon Tumor Growth In Vitro

Maryam Farajzadeh , Mohammad-Salar Hosseini, Farzaneh Eshaghi, Samira Mohebbi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2024;2: e19 | Published on: 2024 Nov 17. doi: 10.34172/ijdrc.2024.e19

Article

PDF

XML

Cited By:

Original Article

10. The Inhibition of CD73 in Conjunction With the Blockade of Apoptosis Inhibitors Significantly Impedes the Advancement of Cancer via Pro-Apoptotic Mechanisms

Maryam Farajzadeh , Mohammad-Salar Hosseini, Mehran Mozaffari, Farzaneh Sadat Eshaghi, Fatemeh Alian, Sakineh Hajebrahimi, Sanam Nami, Farhad Jadidi-Niaragh*

Int J Drug Res Clin. 2024;2: e27 | Published on: 2024 Dec 18. doi: 10.34172/ijdrc.2024.e27

Article

PDF

XML

Cited By:

Submit Your Paper Editorial Board Instructions For Authors Aims and Scope Editorial Policies Contact Us Indexing and Abstracting Messages Announcements Archive

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website.